DS9051
/ Daiichi Sankyo
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 21, 2025
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Daiichi Sankyo | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Adrenal Cortex Carcinoma • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
September 25, 2025
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=40 | Not yet recruiting | Sponsor: Daiichi Sankyo
First-in-human • New P1 trial • Adrenal Cortex Carcinoma • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1